ER stress is involved in Aβ-induced GSK-3β activation and tau phosphorylation

Journal of Neuroscience Research

Volumn 86, Issue 9, 2008, Pages 2091-2099

  Resende, Rosa ^a   Ferreiro, Elisabete ^a   Pereira, Cláudia ^a   Oliveira, Catarina Resende ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

A oligomers; Alzheimer's disease; Endoplasmic reticulum; Glycogen synthase kinase (GSK 3 ); Tau phosphorylation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; DANTROLENE; GLYCOGEN SYNTHASE KINASE 3ALPHA; OLIGOMER; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; TAU PROTEINS;

EID: 48249157930     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21648     Document Type: Article

References (49)

1. Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K. 1994. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A 91:5562-5566.
2. Avila J. 2006. Tau protein, the main component of paired helical filaments. J Alzheimers Dis 9:171175.
3. Balaraman Y, Limaye AR, Levey AI, Srinivasan S. 2006. Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell Mol Life Sci 63:1226-1235.
4. Brewster JL, Linseman DA, Bouchard RJ, Loucks FA, Precht TA, Esch EA, Heidenreich KA. 2006. Endoplasmic reticulum stress and trophic factor withdrawal activate distinct signaling cascades that induce glycogen synthase kinase-3 beta and a caspase-9-dependent apoptosis in cerebellar granule neurons. Mol Cell Neurosci 32:242-253.
5. Caccamo A, Oddo S, Tran LX, LaFerla FM. 2007. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol 170:1669-1675.
6. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277:32046-32053.
7. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL. 2007. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers. Neurobiol Aging [Epub ahead of print].
8. De Sarno P, Bijur GN, Zmijewska AA, Li X, Jope RS. 2006. In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors. Neurobiol Aging 3:413-422.
9. Deshpande A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26:6011-6018.
10. Dunn N, Holmes C, Mullee M. 2005. Does lithium therapy protect against the onset of dementia? Alzheimer Dis Assoc Disord 19:20-22.
11. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. 1998. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 143:777-794.
12. Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM. 2006 An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 23:669-678.
13. Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391-426.
14. Hertz E, Yua CH, Hertz L, Juurlink BHJ, Schousboe A. 1989. Preparation of primary cultures of mouse cortical neurons. In: Shahar A, De Vellis J, Vernadakis A, Haber B, eds. A dissection and tissue culture manual of the nervous system. New York: Alan R. Liss Inc. p 183-186.
15. Ishiguro K, Omori A, Takamatsu M, Sato K, Arioka M, Uchida T, Imahori K. 1992. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci Lett 148:202-206.
16. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, Uchida T, Imahori K. 1993. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325:167-172.
17. Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH. 2003. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol 163:1057-1067.
18. Jing P, Jin Q, Wu J, Zhang XJ. 2008. GSK3beta mediates the induced expression of synaptic acetylcholinesterase during apoptosis. J Neurochem 140:409-419.
19. Koh SH, Noh MY, Kim SH. 2008. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. Brain Res 118:254-262.
20. LaFerla FM, Oddo S. 2005. Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11:170-176.
21. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 98:6448-6453.
22. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. 2006. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440:352-357.
23. Liu SJ, Zhang AH, Li HL, Wang Q, Deng HM, Netzer WJ, Xu H, Wang JZ. 2003. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem 87:1333-1344.
24. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S, et al. 1994. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4:1077-1086.
25. Ma QL, Lim GP, Harris-White ME, Yang F, Ambegaokar SS, Ubeda OJ, Glabe CG, Teter B, Frautschy SA, Cole GM. 2006. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. J Neurosci Res 83:374-384.
26. Magrané J, Rosen KM, Smith RC, Walsh K, Gouras GK, Querfurth HW. 2005. Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 25:10960-10969.
27. Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E. 2004. MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 167:99-110.
28. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival. J Immunol Meth 65:55-63.
29. Nakagawa T, Yuan J. 2000. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150:887-894.
30. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM. 2006. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 281:1599-1604.
31. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. 1999. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58:1010-1019.
32. Plattner F, Angelo M, Giese KP. 2006. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 281:25457-25465.
33. Price DL, Sisodia SS, Borchelt DR. 1998. Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282:1079-1083.
34. Rao RV, Peel A, Logvinova A, del Ri G, Hermel E, Yokota T, Goldsmith PC, Ellerby LM, Ellerby HM, Bredesen DE. 2002. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514:122-128.
35. Rapoport M, Dawson HN, Binde LI, Vitek MP, Ferreira A. 2002. Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99:6364-6369.
36. 2+ homeostasis. Brain Res 1143:11-21.
37. Shea TB, Prabhakar S, Ekinci FJ. 1997. Beta-amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: differential involvement of the calpain/protein kinase C system. J Neurosci Res 49:759-768.
38. Song LP, Jope RS. 2002. Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J Biol Chem 277:44701-44708.
39. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. 2002. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051-1063.
40. Takadera T, Ohyashiki T. 2007. Caspase-dependent apoptosis induced by calcineurin inhibitors was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical cells. Brain Res 1133:20-26.
41. Takadera T, Yoshikawa R, Ohyashiki T. 2006. Thapsigargin-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells. Neurosci Lett 408:124-128.
42. Takashima A, Noguchi K, Michel G, Mercken M, Hoshi M, Ishiguro K, Imahori K. 1996. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci Lett 203:33-36.
43. Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K. 1993. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A. 90:7789-7793.
44. Terry RD. 1996. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55:1023-1025.
45. Tomidokoro Y, Ishiguro K, Harigaya Y, Matsubara E, Ikeda M, Park JM, Yasutake K, Kawarabayashi T, Okamoto K, Shoji M. 2001. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett 299:169-172.
46. Tseng BP, Green KN, Chan JL, Blurton-Jones M, Laferla FM. 2007. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging [Epub ahead of print].
47. Wang JZ, Grundke-Iqbal I, Iqbal K. 2007. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25:59-68.
48. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K. 1996. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol (Berl) 92:232-241.
49. 2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells. Neurochem Int 48:696-702.